Sandbox:Madhu: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:


=== Discovery ===
=== Discovery ===
* DES was first described by Osgood, in 1889 in 6 patients who presented with chest pain and dysphagia.
* DES was first described by Osgood, in 1889 in 6 patients who presented with chest pain and dysphagia.<ref name="pmid248038782">{{cite journal| author=Achem SR| title=Diffuse esophageal spasm in the era of high-resolution manometry. | journal=Gastroenterol Hepatol (N Y) | year= 2014 | volume= 10 | issue= 2 | pages= 130-3 | pmid=24803878 | doi= | pmc=4011379 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24803878  }}</ref>


* Creamer (1954) made the first manometric descriptions of DES.
* Creamer (1954) made the first manometric descriptions of DES.
References


== Classification of DES ==
== Classification of DES ==

Revision as of 14:12, 31 October 2017


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Madhu Sigdel

Historical Perspective

Discovery

  • DES was first described by Osgood, in 1889 in 6 patients who presented with chest pain and dysphagia.[1]
  • Creamer (1954) made the first manometric descriptions of DES.

References

Classification of DES

  • There is no established system for the classification of DES although it is categorized as one of the major disorders of peristalsis according to The Chicago Classification v.3.0.

Risk Factors

  • Common risk factors in the development of Diffuse Esophageal Spasm include Age (60-80 years), presence of GERD, Hypertension, anxiety or depression, and drinks (eg. red wine, very hot or cold liquid or fluid).

Pathophysiology

Pathogenesis

  • The exact pathogenesis of DES is not fully understood. However, current high-resolution manometric studies suggest impairment of inhibitory myenteric plexus neuron. These neurons use nitric oxide (NO) as neurotransmitter. Hence, these patients may also have dysregulation of endogenous NO synthesis or/and degradation[2]. The final result is premature and rapidly propagated or simultaneous contraction of smooth muscles of distal esophagus.

References

  1. Achem SR (2014). "Diffuse esophageal spasm in the era of high-resolution manometry". Gastroenterol Hepatol (N Y). 10 (2): 130–3. PMC 4011379. PMID 24803878.
  2. Orlando RC, Bozymski EM (1973). "Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm". N Engl J Med. 289 (1): 23–5. doi:10.1056/NEJM197307052890106. PMID 4196712.

Natural History, Complications, and Prognosis

Natural History

  • The symptoms of DES usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
  • The symptoms of (disease name) typically develop ___ years after exposure to ___.
  • If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

Complications

  • Common complications of [disease name] include:
    • [Complication 1]
    • [Complication 2]
    • [Complication 3]

Prognosis

  • Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
  • Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
  • The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
  • [Subtype of disease/malignancy] is associated with the most favorable prognosis.
  • The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.

References

Diagnostic Criteria

  • The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
    • [Criterion 1]
    • [Criterion 2]
    • [Criterion 3]
    • [Criterion 4]
  • The diagnosis of DES is based on The Chicago Classification criteria using high resolution esophageal manometry
    • [Criterion 1]
    • [Criterion 2]
    • [

References